Complement C3 as a marker of cardiometabolic risk in psoriasis.
about
Emerging risk biomarkers in cardiovascular diseases and disordersComplement C3 Is the Strongest Predictor of Whole-Body Insulin Sensitivity in Psoriatic Arthritis.High prevalence of metabolic syndrome in patients with psoriasis in Lebanon: a prospective study.Influence of psoriasis on circulatory system function assessed in echocardiography.Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment.Serum levels of adipokines and cytokines in psoriasis patients: a systematic review and meta-analysis.
P2860
Complement C3 as a marker of cardiometabolic risk in psoriasis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Complement C3 as a marker of cardiometabolic risk in psoriasis.
@en
Complement C3 as a marker of cardiometabolic risk in psoriasis.
@nl
type
label
Complement C3 as a marker of cardiometabolic risk in psoriasis.
@en
Complement C3 as a marker of cardiometabolic risk in psoriasis.
@nl
prefLabel
Complement C3 as a marker of cardiometabolic risk in psoriasis.
@en
Complement C3 as a marker of cardiometabolic risk in psoriasis.
@nl
P2860
P50
P1476
Complement C3 as a marker of cardiometabolic risk in psoriasis.
@en
P2093
Manuela Selores
Nuno Bettencourt
P2860
P2888
P304
P356
10.1007/S00403-014-1467-5
P577
2014-05-22T00:00:00Z